Concise review: Circulating endothelial progenitor cells for vascular medicine

Stem Cells

Volumn 29, Issue 11, 2011, Pages 1650-1655

  Asahara, Takayuki ^a,b   Kawamoto, Atsuhiko ^b   Masuda, Haruchika ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b INSTITUTE OF BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

Author keywords

Angiogenesis; Cell therapy; Ischemia; Regeneration; Stem progenitor cell

Indexed keywords

ACUTE HEART INFARCTION; ANGINA PECTORIS; ANGIOGENESIS; CELL GROWTH; CELL KINETICS; CELL REGENERATION; CLINICAL EFFECTIVENESS; CRITICAL LIMB ISCHEMIA; ENDOTHELIAL PROGENITOR CELL; HEMATOPOIETIC STEM CELL; HUMAN; LIMB ISCHEMIA; NONHUMAN; SHORT SURVEY; STEM CELL MOBILIZATION; STEM CELL RESEARCH; STEM CELL TRANSPLANTATION;

ANIMALS; ENDOTHELIAL CELLS; HUMANS; ISCHEMIA; NEOVASCULARIZATION, PHYSIOLOGIC; STEM CELL TRANSPLANTATION; STEM CELLS;

ANIMALIA;

EID: 80054958024     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.745     Document Type: Short Survey

References (72)

1. Asahara T, Murohara T, Sullivan A et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964-7. (Pubitemid 27087709)
2. Shi Q, Rafii S, Wu MH et al. Evidence for circulating bone marrow-derived endothelial cells. Blood 1998;92:362-367. (Pubitemid 28323695)
3. Asahara T, Masuda H, Takahashi T et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999;85:221-228. (Pubitemid 29377293)
4. Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992;267:10931-10934.
5. Risau W, Sariola H, Zerwes HG et al. Vasculogenesis and angiogenesis in embryonic-stem-cell-derived embryoid bodies. Development 1988;102:471-478. (Pubitemid 18084930)
6. Isner JM, Asahara T. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J Clin Invest 1999;103:1231-1236. (Pubitemid 29218292)
7. Bailey AS, Jiang S, Afentoulis M et al. Transplanted adult hematopoietic stems cells differentiate into functional endothelial cells. Blood 2004;103:13-19. (Pubitemid 38029913)
8. Pelosi E, Valtieri M, Coppola S et al. Identification of the hemangioblast in postnatal life. Blood 2002;100:3203-3208. (Pubitemid 35217068)
9. Grant MB, May WS, Caballero S et al. Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nat Med 2002;8:607-612. (Pubitemid 34633439)
10. Ingram DA, Caplice NM, Yoder MC. Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells. Blood 2005;106:1525-1531. (Pubitemid 41208561)
11. Aicher A, Rentsch M, Sasaki K et al. Nonbone marrow-derived circulating progenitor cells contribute to postnatal neovascularization following tissue ischemia. Circ Res 2007;100:581-589. (Pubitemid 46673268)
12. Timmermans F, Van Hauwermeiren F, De Smedt M et al. Endothelial outgrowth cells are not derived from CD133+ cells or CD45+ hematopoietic precursors. Arterioscler Thromb Vasc Biol 2007;27:1572-1579. (Pubitemid 46986112)
13. Flamme I, Risau W. Induction of vasculogenesis and hematopoiesis in vitro. Development 1992;116:435-439.
14. Timmermans F, Plum J, Yoder MC et al. Endothelial progenitor cells: Identity defined? J Cell Mol Med 2009;13:87-102.
15. Masuda H, Alev C, Akimaru H et al. Methodological development of a clonogenic assay to determine endothelial progenitor cell potential. Circ Res 2011;109:20-37.
16. Kwon SM, Eguchi M, Wada M et al. Specific Jagged-1 signal from bone marrow microenvironment is required for endothelial progenitor cell development for neovascularization. Circulation 2008;118:157-165.
17. Tanaka R, Wada M, Kwon SM et al. The effects of flap ischemia on normal and diabetic progenitor cell function. Plast Reconstr Surg 2008;121:1929-1942.
18. Kamei N, Kwon SM, Alev C et al. Lnk deletion reinforces the function of bone marrow progenitors in promoting neovascularization and astrogliosis following spinal cord injury. Stem Cells 2010;28:365-375.
19. Dimmeler S, Aicher A, Vasa M et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest 2001;108:391-397. (Pubitemid 32730785)
20. Takahashi T, Kalka C, Masuda H et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999;5:434-438. (Pubitemid 29180584)
21. Vasa M, Fichtlscherer S, Aicher A et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001;89:E1-E7.
22. Kalka C, Masuda H, Takahashi T et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 2000;97:3422-3427. (Pubitemid 30183318)
23. Murohara T, Ikeda H, Duan J et al. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest 2000;105:1527-1536. (Pubitemid 30390303)
24. Sharpe EE,3rd, Teleron AA, Li B et al. The origin and in vivo significance of murine and human culture-expanded endothelial progenitor cells. Am J Pathol 2006;168:1710-1721.
25. Gulati R, Jevremovic D, Peterson TE et al. Diverse origin and function of cells with endothelial phenotype obtained from adult human blood. Circ Res 2003;93:1023-1025. (Pubitemid 37485031)
26. Hur J, Yang HM, Yoon CH et al. Identification of a novel role of T cells in postnatal vasculogenesis: Characterization of endothelial progenitor cell colonies. Circulation 2007;116:1671-1682. (Pubitemid 47537841)
27. Rehman J, Li J, Orschell CM et al. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 2003;107:1164-1169. (Pubitemid 36297209)
28. Shepherd RM, Capoccia BJ, Devine SM et al. Angiogenic cells can be rapidly mobilized and efficiently harvested from the blood following treatment with AMD3100. Blood 2006;108:3662-3667. (Pubitemid 44864542)
29. Bailey AS, Willenbring H, Jiang S et al. Myeloid lineage progenitors give rise to vascular endothelium. Proc Natl Acad Sci USA 2006;103:13156-13161. (Pubitemid 44338932)
30. low cells with stem cell phenotypic and functional features are the major source of circulating endothelial progenitors. Circ Res 2005;97:314-322.
31. Moldovan NI. Role of monocytes and macrophages in adult angiogenesis: A light at the tunnel's end. J Hematother Stem Cell Res 2002;11:179-194. (Pubitemid 34309514)
32. Lin Y, Weisdorf DJ, Solovey A et al. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 2000;105:71-77. (Pubitemid 30036389)
33. Ingram DA, Mead LE, Tanaka H et al. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 2004;104:2752-2760. (Pubitemid 39434958)
34. Hur J, Yoon CH, Kim HS et al. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 2004;24:288-293. (Pubitemid 38197580)
35. Sieveking DP, Buckle A, Celermajer DS et al. Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: Insights from a novel human angiogenesis assay. J Am Coll Cardiol 2008;51:660-668. (Pubitemid 351186872)
36. Wojakowski W, Kucia M, Kazmierski M et al. Circulating progenitor cells in stable coronary heart disease and acute coronary syndromes: Relevant reparatory mechanism? Heart 2008;94:27-33.
37. Losordo DW, Kishore R. A big promise from the very small identification of circulating embryonic stem-like pluripotent cells in patients with acute myocardial infarction. J Am Coll Cardiol 2009;53:10-12.
38. Masuda H, Kalka C, Takahashi T et al. Estrogen-mediated endothelial progenitor cell biology and kinetics for physiological postnatal vasculogenesis. Circ Res 2007;101:598-606. (Pubitemid 351325877)
39. Bauer SM, Goldstein LJ, Bauer RJ et al. The bone marrow-derived endothelial progenitor cell response is impaired in delayed wound healing from ischemia. J Vasc Surg 2006;43:134-141. (Pubitemid 43083521)
40. Ii M, Nishimura H, Iwakura A et al. Endothelial progenitor cells are rapidly recruited to myocardium and mediate protective effect of ischemic preconditioning via "imported" nitric oxide synthase activity. Circulation 2005;111:1114-1120. (Pubitemid 40365471)
41. Iwakura A, Shastry S, Luedemann C et al. Estradiol enhances recovery after myocardial infarction by augmenting incorporation of bone marrow-derived endothelial progenitor cells into sites of ischemiainduced neovascularization via endothelial nitric oxide synthase-mediated activation of matrix metalloproteinase-9. Circulation 2006;113:1605-1614. (Pubitemid 43739420)
42. Murayama T, Tepper OM, Silver M et al. Determination of bone marrow-derived endothelial progenitor cell significance in angiogenic growth factor-induced neovascularization in vivo. Exp Hematol 2002;30:967-72. (Pubitemid 34838899)
43. Urbich C, Aicher A, Heeschen C et al. Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J Mol Cell Cardiol 2005;39:733-742. (Pubitemid 41464410)
44. Dai Y, Ashraf M, Zuo S et al. Mobilized bone marrow progenitor cells serve as donors of cytoprotective genes for cardiac repair. J Mol Cell Cardiol 2008;44:607-617.
45. Kawamoto A, Asahara T, Losordo DW. Transplantation of endothelial progenitor cells for therapeutic neovascularization. Cardiovasc Radiat Med 2002;3:221-225. (Pubitemid 37329397)
46. Wu Y, Ip JE, Huang J et al. Essential role of ICAM-1/CD18 in mediating EPC recruitment, angiogenesis, and repair to the infarcted myocardium. Circ Res 2006;99:315-322. (Pubitemid 44174940)
47. Jujo K, Ii M, Losordo DW. Endothelial progenitor cells in neovascularization of infarcted myocardium. J Mol Cell Cardiol 2008;45:530-544.
48. Miyamoto Y, Suyama T, Yashita T et al. Bone marrow subpopulations contain distinct types of endothelial progenitor cells and angiogenic cytokine-producing cells. J Mol Cell Cardiol 2007;43:627-635. (Pubitemid 47616261)
49. Kocher AA, Schuster MD, Szabolcs MJ et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001;7:430-436. (Pubitemid 32298545)
50. Aicher A, Brenner W, Zuhayra M et al. Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling. Circulation 2003;107:2134-2139. (Pubitemid 36532196)
51. Kawamoto A, Gwon HC, Iwaguro H et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 2001;103:634-637. (Pubitemid 32144189)
52. Kawamoto A, Iwasaki H, Kusano K et al. CD34-positive cells exhibit increased potency and safety for therapeutic neovascularization after myocardial infarction compared with total mononuclear cells. Circulation 2006;114:2163-2169. (Pubitemid 44747897)
53. Schatteman GC, Hanlon HD, Jiao C et al. Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice. J Clin Invest 2000; 106:571-578. (Pubitemid 30666390)
54. Iwasaki H, Kawamoto A, Ishikawa M et al. Dose-dependent contribution of CD34-positive cell transplantation to concurrent vasculogenesis and cardiomyogenesis for functional regenerative recovery after myocardial infarction. Circulation 2006;113:1311-1325. (Pubitemid 43739453)
55. Burt RK, Testori A, Oyama Y et al. Autologous peripheral blood CD133+ cell implantation for limb salvage in patients with critical limb ischemia. Bone Marrow Transplant 2010;45:111-1116.
56. Kawamoto A, Katayama M, Handa N et al. Intramuscular transplantation of G-CSF-mobilized CD34(+) cells in patients with critical limb ischemia: a phase I/IIa, multicenter, single-blinded, dose-escalation clinical trial. Stem Cells 2009;27:2857-2864.
57. Schachinger V, Assmus B, Britten MB et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: Final one-year results of the TOPCARE-AMI Trial. J Am Coll Cardiol 2004;44:1690-1699. (Pubitemid 39369805)
58. Bartunek J, Vanderheyden M, Vandekerckhove B et al. Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: Feasibility and safety. Circulation 2005;112(9 suppl):I178-I183. (Pubitemid 41266671)
59. Li ZQ, Zhang M, Jing YZ et al. The clinical study of autologous peripheral blood stem cell transplantation by intracoronary infusion in patients with acute myocardial infarction (AMI). Int J Cardiol 2007;115:52-56.
60. Stamm C, Westphal B, Kleine HD et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 2003;361:45-46. (Pubitemid 36050962)
61. Stamm C, Kleine HD, Choi YH et al. Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: Safety and efficacy studies. J Thorac Cardiovasc Surg 2007;133:717-725.
62. Boyle AJ, Whitbourn R, Schlicht S et al. Intra-coronary high-dose CD34+ stem cells in patients with chronic ischemic heart disease: A 12-month follow-up. Int J Cardiol 2006;109:21-27.
63. Losordo DW, Schatz RA, White CJ et al. Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: A phase I/IIa double-blind, randomized controlled trial. Circulation 2007;115:3165-3172. (Pubitemid 47018140)
64. Kuroda R, Matsumoto T, Miwa M et al. Local Transplantation of GCSF-mobilized CD34+ cells in a patient with tibial nonunion: A case report. Cell Transplant 2010 [Epub ahead of print].
65. Hung HS, Shyu WC, Tsai CH et al. Transplantation of endothelial progenitor cells as therapeutics for cardiovascular diseases. Cell Transplant 2009;18:1003-1012.
66. Heiss C, Keymel S, Niesler U et al. Impaired progenitor cell activity in age-related endothelial dysfunction. J Am Coll Cardiol 2005;45:1441-1448. (Pubitemid 40615616)
67. Ii M, Takenaka H, Asai J et al. Endothelial progenitor thrombospondin-1 mediates diabetes-induced delay in reendothelialization following arterial injury. Circ Res 2006;98:697-704.
68. Imanishi T, Moriwaki C, Hano T et al. Endothelial progenitor cell senescence is accelerated in both experimental hypertensive rats and patients with essential hypertension. J Hypertens 2005;23:1831-1837. (Pubitemid 41830423)
69. Kondo T, Hayashi M, Takeshita K et al. Smoking cessation rapidly increases circulating progenitor cells in peripheral blood in chronic smokers. Arterioscler Thromb Vasc Biol 2004;24:1442-1447. (Pubitemid 39050438)
70. Michaud SE, Dussault S, Haddad P et al. Circulating endothelial progenitor cells from healthy smokers exhibit impaired functional activities. Atherosclerosis 2006;187:423-432. (Pubitemid 43963027)
71. Pesce M, Orlandi A, Iachininoto MG et al. Myoendothelial differentiation of human umbilical cord blood-derived stem cells in ischemic limb tissues. Circ Res 2003;93:e51-e62.
72. Ott I, Keller U, Knoedler M et al. Endothelial-like cells expanded from CD34+ blood cells improve left ventricular function after experimental myocardial infarction. FASEB J 2005;19:992-994. (Pubitemid 40827728)